Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ruicong Ma, Gentao Li, Xue Wang, Yajuan Bi & Youcai Zhang. (2021) Inhibitory effect of sixteen pharmaceutical excipients on six major organic cation and anion uptake transporters. Xenobiotica 51:1, pages 95-104.
Read now
Read now
Lucie Hyrsova, Tomas Smutny, Frantisek Trejtnar & Petr Pavek. (2016) Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation. Drug Metabolism Reviews 48:2, pages 139-158.
Read now
Read now
Fabian Müller & Martin F Fromm. (2011) Transporter-Mediated Drug–Drug Interactions. Pharmacogenomics 12:7, pages 1017-1037.
Read now
Read now
Anne T Nies & Matthias Schwab. (2010) Organic cation transporter pharmacogenomics and drug–drug interaction. Expert Review of Clinical Pharmacology 3:6, pages 707-711.
Read now
Read now
Christina Fahrmayr, Martin F. Fromm & Jörg König. (2010) Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects. Drug Metabolism Reviews 42:3, pages 380-401.
Read now
Read now
Jürgen Kindla, Martin F Fromm & Jörg König. (2009) In vitro evidence for the role of OATP and OCT uptake transporters in drug–drug interactions. Expert Opinion on Drug Metabolism & Toxicology 5:5, pages 489-500.
Read now
Read now
Articles from other publishers (26)
Jianwei Jiang, Lijun Luo, Ziqian Zhang, Xiao Liu, Naihong Chen, Yan Li & Li Sheng. (2024) The Active Glucuronide Metabolite of the Brain Protectant IMM-H004 with Poor Blood–Brain Barrier Permeability Demonstrates a High Partition in the Rat Brain via Multiple Mechanisms. Pharmaceutics 16:3, pages 330.
Crossref
Crossref
Sonia Saib, Sophie Hodin, Zhiguo He, Olivier Delézay & Xavier Delavenne. (2020) Is the human model RPTEC/TERT1 a relevant model for assessing renal drug efflux?. Fundamental & Clinical Pharmacology 35:4, pages 732-743.
Crossref
Crossref
Anusha Balla, Yoo-Seong Jeong, Hyo-Jung Kim, Yun-Jong Lee, Suk-Jae Chung, Yoon-Jee Chae & Han-Joo Maeng. (2021) Effects of 1α,25-Dihydroxyvitamin D3 on the Pharmacokinetics of Procainamide and Its Metabolite N-Acetylprocainamide, Organic Cation Transporter Substrates, in Rats with PBPK Modeling Approach. Pharmaceutics 13:8, pages 1133.
Crossref
Crossref
Heinz Bönisch. 2021. Organic Cation Transporters in the Central Nervous System. Organic Cation Transporters in the Central Nervous System
119
167
.
Yi Peng, Lu Chen, Sheng Ye, Yu Kang, Junqing Liu, Su Zeng & Lushan Yu. (2020) Research and development of drug delivery systems based on drug transporter and nano-formulation. Asian Journal of Pharmaceutical Sciences 15:2, pages 220-236.
Crossref
Crossref
Hermann Koepsell. (2019) Organic Cation Transporters in Health and Disease. Pharmacological Reviews 72:1, pages 253-319.
Crossref
Crossref
Yoo-Seong Jeong, Anusha Balla, Kwang-Hoon Chun, Suk-Jae Chung & Han-Joo Maeng. (2019) Physiologically-Based Pharmacokinetic Modeling for Drug-Drug Interactions of Procainamide and N-Acetylprocainamide with Cimetidine, an Inhibitor of rOCT2 and rMATE1, in Rats. Pharmaceutics 11:3, pages 108.
Crossref
Crossref
Sungwoo Hyung, Wonji Pyeon, Ji Eun Park, Yoo-Kyung Song & Suk-Jae Chung. (2017) The conditional stimulation of rat organic cation transporter 2, but not its human ortholog, by mesoridazine: the possibility of the involvement of the high-affinity binding site of the transporter in the stimulation. Journal of Pharmacy and Pharmacology 69:11, pages 1513-1523.
Crossref
Crossref
Anton Ivanyuk, Françoise Livio, Jérôme Biollaz & Thierry Buclin. (2017) Renal Drug Transporters and Drug Interactions. Clinical Pharmacokinetics 56:8, pages 825-892.
Crossref
Crossref
Harma Ellens, Marta Johnson, Sarah K. Lawrence, Cory Watson, Liangfu Chen & Lauren E. Richards-Peterson. (2017) Prediction of the Transporter-Mediated Drug-Drug Interaction Potential of Dabrafenib and Its Major Circulating Metabolites. Drug Metabolism and Disposition 45:6, pages 646-656.
Crossref
Crossref
Ivan Mihaljević, Marta Popović, Roko Žaja, Nikola Maraković, Goran Šinko & Tvrtko Smital. (2017) Interaction between the zebrafish (Danio rerio) organic cation transporter 1 (Oct1) and endo- and xenobiotics. Aquatic Toxicology 187, pages 18-28.
Crossref
Crossref
Shuichi Kishimoto, Megumi Yasuda, Ryosuke Suzuki & Shoji Fukushima. (2016) Intracellular uptake of an antitumor-active azole-bridged dinuclear platinum(II) complex in cisplatin-resistant tumor cells. BioMetals 29:6, pages 1075-1083.
Crossref
Crossref
Tore Bjerregaard Stage, Moa P. Lee, Jesper Hallas, Mette Marie Hougaard Christensen, Kim Brøsen, Kaare Christensen, Joshua J. Gagne & Anton Pottegård. (2016) Early Discontinuation of Metformin in Individuals Treated with Inhibitors of Transporters of Metformin. Basic & Clinical Pharmacology & Toxicology 118:6, pages 487-495.
Crossref
Crossref
Omar T. Hassan, Reem T. Hassan & Rohit R. Arora. (2016) Organic Cation Transporter–Mediated Clearance of Cardiovascular Drugs. American Journal of Therapeutics 23:3, pages e855-e861.
Crossref
Crossref
Tore Bjerregaard Stage, Kim Brøsen & Mette Marie Hougaard Christensen. (2015) A Comprehensive Review of Drug–Drug Interactions with Metformin. Clinical Pharmacokinetics 54:8, pages 811-824.
Crossref
Crossref
John G. Hardy, Megan N. Amend, Sydney Geissler, Vincent M. Lynch & Christine E. Schmidt. (2015) Peptide-directed assembly of functional supramolecular polymers for biomedical applications: electroactive molecular tongue-twisters (oligoalanine–oligoaniline–oligoalanine) for electrochemically enhanced drug delivery. Journal of Materials Chemistry B 3:25, pages 5005-5009.
Crossref
Crossref
J Nirmal, S B Singh, N R Biswas, V Thavaraj, R V Azad & T Velpandian. (2013) Potential pharmacokinetic role of organic cation transporters in modulating the transcorneal penetration of its substrates administered topically. Eye 27:10, pages 1196-1203.
Crossref
Crossref
Jörg König, Fabian Müller & Martin F. Fromm. (2013) Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects. Pharmacological Reviews 65:3, pages 944-966.
Crossref
Crossref
Douglas B. Kell, Paul D. Dobson, Elizabeth Bilsland & Stephen G. Oliver. (2013) The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. Drug Discovery Today 18:5-6, pages 218-239.
Crossref
Crossref
Yurong Lai. 2013. Transporters in Drug Discovery and Development. Transporters in Drug Discovery and Development
455
631
.
J Wang, T P Hughes, C H Kok, V A Saunders, A Frede, K Groot-Obbink, M Osborn, A A Somogyi, R J D'Andrea & D L White. (2012) Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells. British Journal of Cancer 106:11, pages 1772-1778.
Crossref
Crossref
Sabine Klatt, Martin F. Fromm & Jörg König. (2011) Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs. Pharmaceutics 3:4, pages 680-705.
Crossref
Crossref
Jacob Kramer Jacobsen, Bente Jensen, Christian Skonberg, Steen Honoré Hansen & Lassina Badolo. (2011) Time-course activities of Oct1, Mrp3, and cytochrome P450s in cultures of cryopreserved rat hepatocytes. European Journal of Pharmaceutical Sciences 44:3, pages 427-436.
Crossref
Crossref
Anne T. Nies, Hermann Koepsell, Katja Damme & Matthias Schwab. 2011. Drug Transporters. Drug Transporters
105
167
.
Hiroshi Mizuuchi. (2010) Topics on transporter-mediated renal excretion and drug–drug interaction.. Folia Pharmacologica Japonica 135:1, pages 30-33.
Crossref
Crossref
Ken-ichi Umehara, Naoyuki Nakada, Kiyoshi Noguchi, Takafumi Iwatsubo, Takashi Usui & Hidetaka Kamimura. (2009)
Investigation of Long-Term Retention of Unchanged (−)-
N
-{2-[(
R
)-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide, A Novel “Funny” If Current Channel Inhibitor, and Its Metabolites in the Eyeball and Thoracic Aorta of Rats
. Drug Metabolism and Disposition 37:11, pages 2137-2144.
Crossref
Crossref